Skip to main content

Table 1 Comparison of baseline characteristics

From: The effect of a pharmacist consultation on pregnant women’s quality of life with a special focus on nausea and vomiting: an intervention study

Baseline characteristics

Intervention

group*

n = 119

Control

group*

n = 126

General birthing population in Norway/other studies

Gestation week, mean (SD, range)a

7.6 (2.1, 3–12)

7.5 (2.3, 3–12)

Maternal age, mean (SD, range)

31.3 (4.0, 21–41)

31.1 (4.6, 18–44)

31.0 (4.9)c

Primiparous, %

58.8

48.4

42.4c

University/college degree, %

82.4

83.3

51.5d

Employed, %

89.9

81.0

86.4e

Married/cohabitating, %

97.5

96.0

93.6c

≥ 1 chronic condition, %

42.9

46.0

PUQE scoreb, mean (SD, range)

6.4 (2.8, 3–14)

6.1 (2.5, 3–15)

Moderate or severe NVPb, %

47.9

45.2

91.2f

Infertility treatment in current pregnancy, %

10.9

16.7

3−4g

Folic acid supplement before and during pregnancy, %

97.5

98.4

33.8/79.1c,h

Smoking in pregnancy, %

1.7

0.8

3.4c

Alcohol in pregnancy, %

5.0

3.2

4.1i

QOLS, mean (SD, range)

89.0 (12.5, 42–112)

91.1 (10.2, 62–112)

81 (12.8)f

  1. Comparison of baseline characteristics of the study participants according to the two study groups. Characteristics of the general birthing population of Norway from other sources are also presented
  2. Abbreviations: SD standard deviation; NVP nausea and vomiting in pregnancy; QOLS Quality of Life Scale
  3. *The Chi-Squared test was used to compare categorical variables between the two study groups. The two-sided Students t-test were used to compare the continuous variables (gestation week, maternal age, PUQE, and QOLS). No results indicated statistical significance (all p ≥ 0.05)
  4. aTotal number intervention group, n = 118; total number control group, n = 124. Three women with unknown gestation week at baseline
  5. bNVP severity based on the Pregnancy-Unique Quantification of Emesis (PUQE) score: mild ≤ 6; moderate 7–12; severe ≥ 13
  6. cData from the Norwegian Medical Birth Registry for 2018
  7. dData from Statistics Norway, women aged 20–39 in 2018
  8. eData from Statistics Norway, women aged 25–39 in 2018
  9. fHeitmann et al. [2]
  10. gData from the Norwegian Biotechnology Advisory Board
  11. hFolic acid supplement before/during pregnancy
  12. iMårdby et al. [35]